Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Key facts

Sponsor

Aichi Cancer Center

Principal Investigator

Nobukazu Fuwa

Aichi Cancer Center

Intervention

docetaxel(drug)

Enrollment

50 enrolled

Eligibility

All sexes

Timeline

2004 – 2008

Study locations (9)

• Aichi Cancer Center, Nagoya, Aichi-ken, Japan
• Hirosaki University, School of Medicine, Hirosaki, Aomori, Japan
• Chiba University, Chiba, Chiba, Japan
• Yokohama City University, Yokohama, Kanagawa, Japan
• Shinshu University Health Center, Matsumoto, Nagano, Japan
• Nara Medical University Cancer Center, Nara, Nara, Japan
• Graduate School of Medical Science at the University of Ryukyu, Okinawa, Okinawa, Japan
• Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
• National Hospital Organization - Medical Center of Kure, Hiroshima, Japan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of the hypopharynx

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07063212
  A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
  Memorial Sloan Kettering Cancer Center
• RECRUITINGPHASE1NCT06761937
  Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients
  Erasmus Medical Center
• RECRUITINGPHASE3NCT06706401
  Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
  Centre Leon Berard
• RECRUITINGNCT06380686
  Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
  AIO-Studien-gGmbH
• RECRUITINGPHASE3NCT06525220
  A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
  Merus B.V.
• RECRUITINGPHASE3NCT05333523
  Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
  Radboud University Medical Center
• RECRUITINGPHASE2NCT04858269
  First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
  Wake Forest University Health Sciences
• ACTIVE NOT RECRUITINGPHASE3NCT04590963
  Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
  AstraZeneca

See all trials for Squamous cell carcinoma of the hypopharynx →